A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares
Clinical trial NCT06013969 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06013969
- Sponsor
- LEO Pharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-22
- Primary completion
- 2026-07-23
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.